Cochrane Insurance Medicine: looking back, looking forward
- PDF / 255,594 Bytes
- 4 Pages / 595.276 x 841.89 pts (A4) Page_size
- 75 Downloads / 225 Views
Cochrane Insurance Medicine: looking back, looking forward Adri a n Ver b el , Regi n a K u n z , E m i l i e F r i b e rg , Ja n H o ving Introduction Research in the field of insurance medicine (IM) has increased in a number of countries stimulated by the recognition of IM as a specialty with particular broad research needs. In several countries, research lines have been established in the areas of IM or disability evaluation, such as the Dutch Research Center for Insurance Medicine, the unit Evidence-based Insurance Medicine, Research & Education (EbIM) at the University of Basel in Switzerland, and the Division of Insurance Medicine at Karolinska Institutet in Sweden. In the past decade, the principles of evidence-based medicine (EBM) have been implemented in both research and education, and many EBM enthusiasts are involved in Cochrane. Five years ago, these developments led to the creation of the field Cochrane Insurance Medicine (CIM) by researchers from Switzerland, the Netherlands, Sweden and Canada. Since then, CIM’s aim has been to make IM more evidencebased, promoting the production and use of scientific evidence to support IM practice.1 CIM has also become a platform for IM researchers and professionals to connect and collaborate. In celebration of the 5-year existence of CIM (CIM Jubilee Symposium), we reflect on some of the developments in CIM and present projects and opportunities for the years to come.
A. Verbel, MD, MSc, Evidence-based Insurance Medicine, EbIM, Research & Education, Dept. Clinical Research, University of Basel, University Hospital Basel, Switzerland R. Kunz, MD, MSc, Professor of Insurance Medicine, Evidence-based Insurance Medicine, EbIM, Research & Education, Dept. Clinical Research, University of Basel, University Hospital Basel, Switzerland E. Friberg, PhD, Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Sweden. J.L. Hoving, PhD, Amsterdam UMC, location Academic Medical Center, University of Amsterdam, Coronel Institute for Occupational Health, Amsterdam Public Health research institute, Amsterdam, the Netherlands Author for correspondence: [email protected]
38
Knowledge translation in Cochrane and CIM Cochrane defines knowledge translation (KT) as the process of supporting the use of evidence by those who need it.2 Since its creation, CIM has developed KT strategies and products to enhance the production, dissemination and use of evidence among IM professionals. In 2016, CIM conducted a survey aiming to identify the evidence and training needs of physicians and other professionals working in IM. The survey had the support from the European Union of Medicine in Assurance and Social Security (EUMASS), the International Committee for Insurance Medicine (ICLAM) and eight disability and accident insurance organizations in eight European countries (Belgium, Finland, France, Germany, Netherlands, Spain, Sweden, and Switzerland). The results indicated, against common believes, that the needs for evidence syntheses seemed to be simila
Data Loading...
